Joined-Up EU Approach Is Key To Continuing COVID-19 Fight
Multi-Stakeholder Approach Must Be Maintained, Medicines For Europe Insists
Executive Summary
At a Medicines for Europe webinar on learning lessons from the COVID-19 pandemic, a clear consensus emerged that a continued co-ordination between industry, regulators and the European Commission was key to both effectively address the current crisis and ensure a greater level of preparedness for similar challenges in future.
You may also be interested in...
Pandemic Perspectives: Cracks In Global Supply Chain Lead To Localization Trend
Weaknesses in the global pharmaceutical supply chain, exposed and exacerbated by the coronavirus pandemic, have led major markets to pursue localization policies aimed at bolstering domestic production capacity. But any significant transformation promises to take many years.
Pandemic Perspectives: Cracks In Global Supply Chain Lead To Localization Trend
Weaknesses in the global pharmaceutical supply chain, exposed and exacerbated by the coronavirus pandemic, have led major markets to pursue localization policies aimed at bolstering domestic production capacity. But any significant transformation promises to take many years.
Europe Must Look Beyond Price To Secure Supply Chain
European procurement models that focus solely on the lowest-cost generics are jeopardizing efforts to strengthen the supply chain and secure investments in local manufacturing, says Christoph Stoller, president of Medicines for Europe.